Crossmark

Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trial

Crossref DOI link: https://doi.org/10.1007/s00595-025-03062-6

Published Online: 2025-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsui, Yuki

Hashimoto, Daisuke

Nakagawa, Nobuhiko

Yamaki, So

Hayashi, Masamichi

Takami, Hideki

Shibuya, Kazuto

Yamada, Suguru

Satoi, Sohei

Fujii, Tsutomu
Funding

Funding for this research was provided by:

Boston Scientific, Koukamei HSM Co.,Ltd.

Nihon Servier, Amino-Up co.
License Information

Text and Data Mining valid from 2025-05-17

Version of Record valid from 2025-05-17
More Information

Article History

Received: 9 February 2025

Accepted: 23 April 2025

First Online: 17 May 2025

Declarations

:

: S.S. received research funding from Nihon Servier, Amino-up Co. and Boston Scientific. There were no COI, except for S.S.

: The study was reviewed and approved (no. 29560) by the Institutional Review Board of the Nagoya University Graduate School of Medicine, Nagoya, Japan.

: Records of patients who refused access to their data were excluded from the analysis.

: UMIN000012241

: N/A.

Document is current

Any future updates will be listed below